Anuncio
Anuncio

SUPN

SUPN logo

Supernus Pharmaceuticals, Inc.

44.41
USD
Patrocinado
-1.14
-2.50%
12 jun, 16:00 UTC -4
Cerrado
exchange

Pre-mercado

44.91

+0.50
+1.13%

Panorámica financiera de Supernus Pharmaceuticals, Inc.

Cap. de Mercado
2.61B
Beta
0.73
Beneficios Por Acción (BPA)
-0.68
Ratio Precio/Valor (P/V) Contable
2.78
Margen de explotación
17.94%
Ratio de Endeudamiento total (D/C)
0.00%
Ratio PER
22.69
Rentabilidad sobre recursos propios (ROE)
12.26%
Ratio de liquidez
1.90%
Flujo de caja libre
45.99M
Perfil de SUPN

Gráfico de Beneficios

Beneficios de SUPN

Valores en tendencia

Micron Technology, Inc. logo
Micron Technology, Inc.$981.61
-1.43%
Space Exploration Technologies Corp. Class A Common Stock logo
Space Exploration Technologies Corp. Class A Common Stock$160.95
+632.26%
Sandisk Corporation Common Stock logo
Sandisk Corporation Common Stock$1980.10
+5.24%
Nvidia Corp logo
Nvidia Corp$205.19
+0.16%
Intel Corp logo
Intel Corp$124.57
+6.51%
Marvell Technology, Inc. Common Stock logo
Marvell Technology, Inc. Common Stock$279.70
-0.36%
Tesla, Inc. Common Stock logo
Tesla, Inc. Common Stock$406.43
+1.82%
Anuncio